Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

VANCOUVER, BC, March 21, 2023 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company”) (TSX: NUMI) (OTCQX: NUMIF), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that Reid Robison, Chief Clinical Officer of Numinus, has contributed to studies published in four peer-reviewed papers thus far in 2023 for…


The product has been added to your cart.

Continue shopping View Cart